We just received notice that our manuscript detailing the methods of DREAM PCR will publish May 2nd in PLoS ONE. We felt it was important to have the methods which navigate gene patents out in the open and not behind a paywall. However, this open source approach has its deficits. This paper sat over 175 days in review at PLoS ONE (submitted Nov 8th 2013). While we agree with their open source policy, Nature Biotech took 47 days and offered a service where we bought 400 copies of the paper to hand to those who didnt have paywall access. We still have copies and over 1900 copies have been downloaded at Nature by subscribers. The interesting aspect of the download rate is that 1600 copies were downloaded in the 1st 45 days highlighting how stale your work can become waiting for the open source option. PLoS might be better served raising there fees and staffing for speed but more importantly, the peer review process needs to publish with the paper (reviewers named and time to review recognized) so transparency brings efficiency. Once embargo (at the open source journal) lifts, well post the link (may 2nd). nature/nbt/journal/v31/n10/abs/nbt.2703.html
Posted on: Mon, 14 Apr 2014 20:35:38 +0000
Trending Topics
Recently Viewed Topics
© 2015